Hero

Genome Identification Diagnostics GmbH

Main Industry
Manufacture of other manufactured articles
updated 
updated 
SaveShare

Key Facts

This company profile is a search result of implisense.com

E-Mail

—

Website

—

Phone

—

Industries

Manufacture of other manufactured articles (C32)

Products and Services

Entwicklung

Size (Revenue & Employees)

Small company

Balance sheet total

2 M €

Purpose

Entwicklung, Herstellung und Vertrieb von Diagnostika sowie Auftragsanalysen, die zum Ziel haben, Nukleinsäuren und immunologische Reaktionen nachzuweisen.

Legal Form

GmbH

Commercial Register

Stuttgart
HRB 401052

Legal Entity Identifier (LEI)

—

Incorporation

00.00.0000

Capital Stock

€ 11,111.11

Historical Names

—

Show more
More? Implisense Plus!

Order Implisense Plus now for full company profiles and complete functionality! You will then have access to our GDPR-compliant real-time contact search, full annual reports, all search filters, complete search results and integrated AI analyses of the business model and management report.

  • Real-time search for contact persons
  • Complete annual reports
  • More search filters and results
Order now

Customer Relationship Intelligence: The Key to Optimizing your Sales Processes

Use our AI-powered assistants to identify the right companies, track current developments and market changes, reach relevant decision-makers and perfect your sales strategy with data-based insights. All seamlessly integrated into your CRM.

  • Find the right companies
  • Keep an eye on your target companies
  • Reach the right decision-makers
  • Increase your closing rate

Learn more

Executive Summary

Implisense Assist gives you the opportunity to use AI to find out about companies via chat, analyze them and much more. We from the Implisense team also provide you with ready-made analyses, e.g., an executive summary and a financial analysis. Just try it out for yourself!

Implisense Plus
implisense assist

profile random user logo

implisense assist

Contacts

  • Rosemarie Preyer

Timeline

Register Announcements

Abschluss des Förderprojektes "KMU-innovativ - Verbundprojekt: Vorhersage der individuellen Immunreaktion auf Organtransplantate (iimOzell) - Teilprojekt: Etablierung des EliSpot-Nachweises der Immunreaktion und der Konservierung für Langzeitbeobachtungen" (BMBF 13GW0500A)

Heute endet das Förderprojekt "KMU-innovativ - Verbundprojekt: Vorhersage der individuellen Immunreaktion auf Organtransplantate (iimOzell) - Teilprojekt: Etablierung des EliSpot-Nachweises der Immunreaktion und der Konservierung für Langzeitbeobachtungen". Es wurde vom BMBF unter dem Förderkennzeichen 13GW0500A für die Genome Identification Diagnostics GmbH mit einer Summe von 425.125,00 Euro gefördert. Die Laufzeit des Projektes betrug 45 Monate.
Funding

Beginn des Förderprojektes "KMU-innovativ - Verbundprojekt: Erforschung eines Diagnoseverfahrens zum Nachweis von nicht tuberkulösen Mykobakterien Infektionen (iNTM) - Teilvorhaben: ELISpot-Testprotokolle für den Nachweis von NTM-Infektionen" (BMBF 13GW0746A)

Heute startet das Förderprojekt "KMU-innovativ - Verbundprojekt: Erforschung eines Diagnoseverfahrens zum Nachweis von nicht tuberkulösen Mykobakterien Infektionen (iNTM) - Teilvorhaben: ELISpot-Testprotokolle für den Nachweis von NTM-Infektionen". Es wird vom BMBF unter dem Förderkennzeichen 13GW0746A für die Genome Identification Diagnostics GmbH mit einer Summe von 583.436,00 Euro gefördert. Die Laufzeit des Projektes beträgt 36 Monate.
Funding

Genome Identification Diagnostics GmbH: Eigenkapital sowie Anlagevermögen steigen 2022!

Das Eigenkapital der Genome Identification Diagnostics GmbH hat sich in 2022 um % auf Euro sowie das Anlagevermögen um % auf Euro bemerkenswert gesteigert. Diese Entwicklung legt eine Zunahme der langfristigen Investitionen nahe. Der aktuellste Jahresabschluss steht nun zur Verfügung und präsentiert detaillierte Einblicke in die finanzielle Entwicklung des Unternehmens.
Annual Reports
Show report

Beginn des Förderprojektes "Verbundprojekt: Verringerung der Krankheitslast von Gebärmutterhalskrebs durch die CERVICARE-Testsysteme, Teilprojekt: Erarbeitung der DNA-Isolationstechnologie und des Algorithmus zur Detektion und Quantifizierung von HPV-DNA" (BMBF 01QE2247B)

Heute startet das Förderprojekt "Verbundprojekt: Verringerung der Krankheitslast von Gebärmutterhalskrebs durch die CERVICARE-Testsysteme, Teilprojekt: Erarbeitung der DNA-Isolationstechnologie und des Algorithmus zur Detektion und Quantifizierung von HPV-DNA". Es wird vom BMBF unter dem Förderkennzeichen 01QE2247B für die Genome Identification Diagnostics GmbH mit einer Summe von 153.815,00 Euro gefördert. Die Laufzeit des Projektes beträgt 36 Monate.
Funding

Abschluss des Förderprojektes "KMU-innovativ-20: MS-Eli - Testsystem zur Identifizierung autoreaktiver T Zellen für eine verbesserte Diagnose von Multipler Sklerose (Teilprojekt A)" (BMBF 161B0568A)

Heute endet das Förderprojekt "KMU-innovativ-20: MS-Eli - Testsystem zur Identifizierung autoreaktiver T Zellen für eine verbesserte Diagnose von Multipler Sklerose (Teilprojekt A)". Es wurde vom BMBF unter dem Förderkennzeichen 161B0568A für die Genome Identification Diagnostics GmbH mit einer Summe von 481.853,00 Euro gefördert. Die Laufzeit des Projektes betrug 45 Monate.
Funding
Latest News

Search in real time for news and events – topic-specific, live, and contextual to the selected company.

Implisense Plus
Show entire timeline

Network

Discover connections between companies via managers, shareholdings, links or addresses here.

Register to see more connections via management and web links. Get access to an interactive network to better understand the environment of this company.

Show more

Products & Technologies

Entwicklung

Genome Identification Diagnostics GmbH is mentioned in public sources in the context of the following products and services. Entwicklung are the most common. The ranking list shown is without guarantee of completeness or correctness.

Register for free and try Implisense Plus!

Register quickly and easily for a free Implisense account. Registered users have access to extended company profiles and receive more comprehensive search results. If you register with a business email address, we will also set up a free 7-day trial for Implisense Plus in a timely manner.

  • Richer Company Profiles
  • Expanded Search Results
  • Personal Favourites

Register now

The company information presented on implisense.com comes from public sources and is verified and aggregated automatically. Implisense cannot guarantee the timeliness, completeness, quality, reliability or accuracy of the data. For questions or suggestions, please use the contact form.

This website uses cookies to provide this service and improve the user experience. Please select the cookies you wish to accept. You can find further information in our data protection declaration.

Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services, we use user statistics such as Google Analytics, which set cookies for user identification. Google Analytics is a service offered by a third party provider.
To improve our services we use proprietary marketing solutions from third parties. These solutions specifically include Google AdWords and Google Optimize, which each set one or more cookies.
Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services, we use user statistics such as Google Analytics, which set cookies for user identification. Google Analytics is a service offered by a third party provider.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services we use proprietary marketing solutions from third parties. These solutions specifically include Google AdWords and Google Optimize, which each set one or more cookies.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.

Save selectionSelect all